Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Johnson

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Molecular Cancer Therapeutics|February 20, 2025
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC TumorsJacqueline P Nguyen, Shorook Na'ara, Liam C Woerner, et al.
Cell Cycle (Georgetown, Tex.)|July 15, 2009
CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patientsSongwen Ju, Hongxia Qiu, Xiaoyue Zhou, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 9, 2016
STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell CarcinomaNoah D Peyser, Lin Wang, Yan Zeng, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 25, 2016
Prevention of Carcinogen-Induced Oral Cancer by SulforaphaneJulie E Bauman, Yan Zang, Malabika Sen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2003
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growthPaul L Leong, Genevieve A Andrews, Daniel E Johnson, et al.
Communications Biology|October 12, 2023
Rare antibody phage isolation and discrimination (RAPID) biopanning enables identification of high-affinity antibodies against challenging targetsDong Hee Chung, Sophie Kong, Nicholas J Young, et al.
Leukemia & Lymphoma|April 5, 2018
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemiaRobert L Redner, Jan H Beumer, Patricia Kropf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck CancerZoya Qureshy, Hua Li, Yan Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Molecular Cancer Therapeutics|February 20, 2025
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC TumorsJacqueline P Nguyen, Shorook Na'ara, Liam C Woerner, et al.
Cell Cycle (Georgetown, Tex.)|July 15, 2009
CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patientsSongwen Ju, Hongxia Qiu, Xiaoyue Zhou, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 9, 2016
STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell CarcinomaNoah D Peyser, Lin Wang, Yan Zeng, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 25, 2016
Prevention of Carcinogen-Induced Oral Cancer by SulforaphaneJulie E Bauman, Yan Zang, Malabika Sen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2003
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growthPaul L Leong, Genevieve A Andrews, Daniel E Johnson, et al.
Communications Biology|October 12, 2023
Rare antibody phage isolation and discrimination (RAPID) biopanning enables identification of high-affinity antibodies against challenging targetsDong Hee Chung, Sophie Kong, Nicholas J Young, et al.
Leukemia & Lymphoma|April 5, 2018
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemiaRobert L Redner, Jan H Beumer, Patricia Kropf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck CancerZoya Qureshy, Hua Li, Yan Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Pageof 11